← Articles

Safety

Product contamination and sterility: two different safety questions

Reading time: 7 minUpdated: 2026-09-23Last reviewed: September 2026By: APEDRA editorial team

A product can contain the wrong drug, a different quantity, or microorganisms. Chemical testing and sterility testing answer different questions; neither is implied by an attractive label.

Chemical identity is one problem

Van Wagoner and colleagues analysed products marketed online as SARMs and found a substantial mismatch between labels and chemical contents. That study concerned chemical identity and quantity; it did not establish sterility or the quality of every product on today's market.

A plausible label, web photograph or one manufacturer's certificate cannot establish what is in a specific purchased unit. Batch identity matters, especially where supply chains or repackaging are opaque.

Microbial safety is another

Injectable preparations add risks from contamination and the injection process itself. Published clinical accounts of infection after anabolic steroid injections illustrate the consequences of failed sterility, while a clear liquid or sealed vial cannot demonstrate microbial safety.

A chemical purity result does not show that a product is sterile. Conversely, sterile manufacture would not prove the declared active ingredient and concentration are correct.

Responding to signs of infection

Spreading redness, warmth, swelling, fever or worsening pain following an injection calls for medical assessment. Severe illness, rapidly spreading symptoms or confusion requires urgent care.

Be candid about what was used and bring packaging or documentation if available. This is about enabling treatment, not validating the supplier's claims.

In short

  • Chemical contents and microbial sterility require separate evidence.
  • A certificate for another batch does not verify the product in hand.
  • Fever or spreading redness following injection needs medical assessment.

Cited studies

These studies provide context for the article; findings may not apply to non-medical use or products sold online.

  1. Van Wagoner RM, Eichner A, Bhasin S, et al. (2017). Chemical composition and labeling of substances marketed as selective androgen receptor modulators and sold via the internet. JAMA.

    Read the study ↗
  2. Driscoll MD, Arora R, Brennan M. (2011). Intramuscular anabolic steroid injection leading to life-threatening clostridial myonecrosis. The Journal of Bone and Joint Surgery.

    Read the study ↗

Unfamiliar terminology is defined in our glossary. How we research and grade evidence is set out in our editorial standards, and errors can be reported through corrections.

This article is educational. It is not medical advice, a dosing recommendation, or an endorsement of use. Speak with a qualified medical practitioner about your circumstances.